FBXL7 and non-small cell lung carcinoma: In order to clarify the molecular mechanism of FBXL7 inhibiting the malignant progression of NSCLC cells, we used TAP-MS to identify the substrate of FBXL7 ubiquitin ligase (Supplementary Table 2).